Rescue right ventricular outflow tract stenting for refractory hypoxic spells

Background While right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and similar physiologies, its utility for relief of refractory hypoxic spells is unclear. Methods Patients who underwent RVOTS for emergency relie...

Full description

Saved in:
Bibliographic Details
Published inCatheterization and cardiovascular interventions Vol. 101; no. 2; pp. 372 - 378
Main Authors Sasikumar, Navaneetha, Mohanty, Satish, Balaji, Seshadri, Kumar, Raman Krishna
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.02.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background While right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and similar physiologies, its utility for relief of refractory hypoxic spells is unclear. Methods Patients who underwent RVOTS for emergency relief of refractory hypoxic spells were identified. Specific modifications to enable expeditious RVOTS included use of stent delivery systems (guiding catheter or long sheath) upfront to minimize catheter exchanges; using coronary wires to cross RVOT initially; stabilizing the catheter with a wire in the aorta while crossing RVOT with a second wire. Results From 2015 to 2022, 11 patients underwent RVOTS for hypoxic spells refractory to medical management. Their median age was 27 days (IQR 8.5–442.5); weight 3.27 kg (2.7–8.96); 9 males. Median pulmonary annulus Z score was −4.13 (IQR−4.85 to −0.86). Thirteen stents with median diameter 5 (4–6.5) mm and length 19 (16–19.75) mm were implanted, fluoroscopy time:13.6 (11–26.3) min; procedure time (60, 30–70 min). All were ventilated. Oxygen saturations improved from 45% (40–60) to 90% (84–92); (p < 0.0001) with no major complications. Postprocedure ventilation was needed for 21 (20–49) hours and 4 required diuretic infusion for pulmonary over‐circulation. Four needed re‐stenting 13 days to 5 months later. At median follow‐up of 7 (4–17) months; 2 died from unrelated causes, 3 underwent surgery (two correction and one aorto‐pulmonary shunt) and 6 await surgery. Conclusion RVOTS enables safe, expeditious and effective short‐term palliation for refractory hypoxic spells. Specific technical modifications facilitate safety, ease and swiftness.
AbstractList BackgroundWhile right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and similar physiologies, its utility for relief of refractory hypoxic spells is unclear.MethodsPatients who underwent RVOTS for emergency relief of refractory hypoxic spells were identified. Specific modifications to enable expeditious RVOTS included use of stent delivery systems (guiding catheter or long sheath) upfront to minimize catheter exchanges; using coronary wires to cross RVOT initially; stabilizing the catheter with a wire in the aorta while crossing RVOT with a second wire.ResultsFrom 2015 to 2022, 11 patients underwent RVOTS for hypoxic spells refractory to medical management. Their median age was 27 days (IQR 8.5–442.5); weight 3.27 kg (2.7–8.96); 9 males. Median pulmonary annulus Z score was −4.13 (IQR−4.85 to −0.86). Thirteen stents with median diameter 5 (4–6.5) mm and length 19 (16–19.75) mm were implanted, fluoroscopy time:13.6 (11–26.3) min; procedure time (60, 30–70 min). All were ventilated. Oxygen saturations improved from 45% (40–60) to 90% (84–92); (p < 0.0001) with no major complications. Postprocedure ventilation was needed for 21 (20–49) hours and 4 required diuretic infusion for pulmonary over‐circulation. Four needed re‐stenting 13 days to 5 months later. At median follow‐up of 7 (4–17) months; 2 died from unrelated causes, 3 underwent surgery (two correction and one aorto‐pulmonary shunt) and 6 await surgery.ConclusionRVOTS enables safe, expeditious and effective short‐term palliation for refractory hypoxic spells. Specific technical modifications facilitate safety, ease and swiftness.
While right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and similar physiologies, its utility for relief of refractory hypoxic spells is unclear.BACKGROUNDWhile right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and similar physiologies, its utility for relief of refractory hypoxic spells is unclear.Patients who underwent RVOTS for emergency relief of refractory hypoxic spells were identified. Specific modifications to enable expeditious RVOTS included use of stent delivery systems (guiding catheter or long sheath) upfront to minimize catheter exchanges; using coronary wires to cross RVOT initially; stabilizing the catheter with a wire in the aorta while crossing RVOT with a second wire.METHODSPatients who underwent RVOTS for emergency relief of refractory hypoxic spells were identified. Specific modifications to enable expeditious RVOTS included use of stent delivery systems (guiding catheter or long sheath) upfront to minimize catheter exchanges; using coronary wires to cross RVOT initially; stabilizing the catheter with a wire in the aorta while crossing RVOT with a second wire.From 2015 to 2022, 11 patients underwent RVOTS for hypoxic spells refractory to medical management. Their median age was 27 days (IQR 8.5-442.5); weight 3.27 kg (2.7-8.96); 9 males. Median pulmonary annulus Z score was -4.13 (IQR-4.85 to -0.86). Thirteen stents with median diameter 5 (4-6.5) mm and length 19 (16-19.75) mm were implanted, fluoroscopy time:13.6 (11-26.3) min; procedure time (60, 30-70 min). All were ventilated. Oxygen saturations improved from 45% (40-60) to 90% (84-92); (p < 0.0001) with no major complications. Postprocedure ventilation was needed for 21 (20-49) hours and 4 required diuretic infusion for pulmonary over-circulation. Four needed re-stenting 13 days to 5 months later. At median follow-up of 7 (4-17) months; 2 died from unrelated causes, 3 underwent surgery (two correction and one aorto-pulmonary shunt) and 6 await surgery.RESULTSFrom 2015 to 2022, 11 patients underwent RVOTS for hypoxic spells refractory to medical management. Their median age was 27 days (IQR 8.5-442.5); weight 3.27 kg (2.7-8.96); 9 males. Median pulmonary annulus Z score was -4.13 (IQR-4.85 to -0.86). Thirteen stents with median diameter 5 (4-6.5) mm and length 19 (16-19.75) mm were implanted, fluoroscopy time:13.6 (11-26.3) min; procedure time (60, 30-70 min). All were ventilated. Oxygen saturations improved from 45% (40-60) to 90% (84-92); (p < 0.0001) with no major complications. Postprocedure ventilation was needed for 21 (20-49) hours and 4 required diuretic infusion for pulmonary over-circulation. Four needed re-stenting 13 days to 5 months later. At median follow-up of 7 (4-17) months; 2 died from unrelated causes, 3 underwent surgery (two correction and one aorto-pulmonary shunt) and 6 await surgery.RVOTS enables safe, expeditious and effective short-term palliation for refractory hypoxic spells. Specific technical modifications facilitate safety, ease and swiftness.CONCLUSIONRVOTS enables safe, expeditious and effective short-term palliation for refractory hypoxic spells. Specific technical modifications facilitate safety, ease and swiftness.
While right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and similar physiologies, its utility for relief of refractory hypoxic spells is unclear. Patients who underwent RVOTS for emergency relief of refractory hypoxic spells were identified. Specific modifications to enable expeditious RVOTS included use of stent delivery systems (guiding catheter or long sheath) upfront to minimize catheter exchanges; using coronary wires to cross RVOT initially; stabilizing the catheter with a wire in the aorta while crossing RVOT with a second wire. From 2015 to 2022, 11 patients underwent RVOTS for hypoxic spells refractory to medical management. Their median age was 27 days (IQR 8.5-442.5); weight 3.27 kg (2.7-8.96); 9 males. Median pulmonary annulus Z score was -4.13 (IQR-4.85 to -0.86). Thirteen stents with median diameter 5 (4-6.5) mm and length 19 (16-19.75) mm were implanted, fluoroscopy time:13.6 (11-26.3) min; procedure time (60, 30-70 min). All were ventilated. Oxygen saturations improved from 45% (40-60) to 90% (84-92); (p < 0.0001) with no major complications. Postprocedure ventilation was needed for 21 (20-49) hours and 4 required diuretic infusion for pulmonary over-circulation. Four needed re-stenting 13 days to 5 months later. At median follow-up of 7 (4-17) months; 2 died from unrelated causes, 3 underwent surgery (two correction and one aorto-pulmonary shunt) and 6 await surgery. RVOTS enables safe, expeditious and effective short-term palliation for refractory hypoxic spells. Specific technical modifications facilitate safety, ease and swiftness.
Background While right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and similar physiologies, its utility for relief of refractory hypoxic spells is unclear. Methods Patients who underwent RVOTS for emergency relief of refractory hypoxic spells were identified. Specific modifications to enable expeditious RVOTS included use of stent delivery systems (guiding catheter or long sheath) upfront to minimize catheter exchanges; using coronary wires to cross RVOT initially; stabilizing the catheter with a wire in the aorta while crossing RVOT with a second wire. Results From 2015 to 2022, 11 patients underwent RVOTS for hypoxic spells refractory to medical management. Their median age was 27 days (IQR 8.5–442.5); weight 3.27 kg (2.7–8.96); 9 males. Median pulmonary annulus Z score was −4.13 (IQR−4.85 to −0.86). Thirteen stents with median diameter 5 (4–6.5) mm and length 19 (16–19.75) mm were implanted, fluoroscopy time:13.6 (11–26.3) min; procedure time (60, 30–70 min). All were ventilated. Oxygen saturations improved from 45% (40–60) to 90% (84–92); (p < 0.0001) with no major complications. Postprocedure ventilation was needed for 21 (20–49) hours and 4 required diuretic infusion for pulmonary over‐circulation. Four needed re‐stenting 13 days to 5 months later. At median follow‐up of 7 (4–17) months; 2 died from unrelated causes, 3 underwent surgery (two correction and one aorto‐pulmonary shunt) and 6 await surgery. Conclusion RVOTS enables safe, expeditious and effective short‐term palliation for refractory hypoxic spells. Specific technical modifications facilitate safety, ease and swiftness.
Author Balaji, Seshadri
Sasikumar, Navaneetha
Kumar, Raman Krishna
Mohanty, Satish
Author_xml – sequence: 1
  givenname: Navaneetha
  orcidid: 0000-0001-8621-8235
  surname: Sasikumar
  fullname: Sasikumar, Navaneetha
  email: drnavni@yahoo.com
  organization: Amrita Institute of Medical Sciences
– sequence: 2
  givenname: Satish
  surname: Mohanty
  fullname: Mohanty, Satish
  organization: Amrita Institute of Medical Sciences
– sequence: 3
  givenname: Seshadri
  orcidid: 0000-0001-5864-5125
  surname: Balaji
  fullname: Balaji, Seshadri
  organization: Oregon Health & Science University
– sequence: 4
  givenname: Raman Krishna
  surname: Kumar
  fullname: Kumar, Raman Krishna
  organization: Amrita Institute of Medical Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36511421$$D View this record in MEDLINE/PubMed
BookMark eNp90TtPwzAQAGALFdEHDPwBZIkFhra24yTNiMJTKkJCHdiixLm0rtI42A4l_x6HFoZKMPn13el8N0S9SlWA0DklE0oImwqRTzziM3aEBtQt45AFb739nkY86KOhMWtCSBSw6AT1vcCnlDM6QM-vYEQDWMvlyuIPqKyWoilTjVVji1JtsdWpsNhY9ySrJS6UxhqK7lLpFq_aWn1KgU0NZWlO0XGRlgbO9usILe7vFvHjeP7y8BTfzMfC8z1XHogZ4X4ehKFICWeCk5yCV7AwcKeAk5nICh5xngFENKMiysCJWUBEAYR7I3S1S1tr9d6AsclGGuEKSCtQjUlY6HPCI0Y7enlA16rRlSvOqTB0kvidutirJttAntRablLdJj99cuB6B4RWxrj__xJKkm4GiZtB8j0DZ6cHVkibWqlcb1NZ_hexlSW0f6dO4vh2F_EFuZGWjQ
CitedBy_id crossref_primary_10_1016_j_ppedcard_2024_101748
crossref_primary_10_1007_s00246_024_03496_8
crossref_primary_10_4103_apc_apc_196_24
crossref_primary_10_4103_cmi_cmi_10_24
crossref_primary_10_1016_j_ppedcard_2025_101822
Cites_doi 10.1136/heartjnl-2013-304155
10.1016/j.jtcvs.2020.06.008
10.1017/S1047951120002334
10.1161/CIRCULATIONAHA.117.029987
10.1136/hrt.2007.135723
10.1161/CIRCINTERVENTIONS.113.000202
10.1161/CIRCINTERVENTIONS.116.003979
10.1161/CIRCINTERVENTIONS.111.965616
10.1016/j.jcin.2017.06.023
10.1007/s00246-021-02684-0
10.1002/ccd.21928
10.1186/s12872-020-01817-2
10.1111/joic.12198
10.1161/CIRCINTERVENTIONS.120.009520
ContentType Journal Article
Copyright 2022 Wiley Periodicals LLC.
2023 Wiley Periodicals LLC.
Copyright_xml – notice: 2022 Wiley Periodicals LLC.
– notice: 2023 Wiley Periodicals LLC.
DBID AAYXX
CITATION
NPM
7T5
7U9
H94
K9.
7X8
DOI 10.1002/ccd.30522
DatabaseName CrossRef
PubMed
Immunology Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Virology and AIDS Abstracts
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts
MEDLINE - Academic
PubMed

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1522-726X
EndPage 378
ExternalDocumentID 36511421
10_1002_ccd_30522
CCD30522
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
05W
0R~
10A
1L6
1OC
29B
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EMOBN
F00
F01
F04
F5P
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HGLYW
HHY
HHZ
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
ROL
RWI
RX1
SUPJJ
SV3
TEORI
UB1
V2E
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
XPP
XV2
~IA
~WT
.GJ
.Y3
31~
53G
AANHP
AAQQT
AASGY
AAYXX
ACBWZ
ACRPL
ACYXJ
ADNMO
AEYWJ
AGHNM
AGQPQ
AGYGG
AZFZN
CITATION
EJD
FEDTE
HF~
HVGLF
LW6
ZGI
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
NPM
7T5
7U9
H94
K9.
7X8
ID FETCH-LOGICAL-c3532-7ec8045d677ca042c40d1e3f2760426408cbf4944bee91b1c9be0d1860cfe043
IEDL.DBID DR2
ISSN 1522-1946
1522-726X
IngestDate Fri Jul 11 15:02:44 EDT 2025
Fri Jul 25 23:58:12 EDT 2025
Mon Jul 21 06:07:49 EDT 2025
Thu Apr 24 22:52:05 EDT 2025
Tue Jul 01 02:16:05 EDT 2025
Wed Jan 22 16:19:17 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Tetralogy of Fallot
hypoxic spells
catheter intervention
right ventricular outflow tract
stenting
Language English
License 2022 Wiley Periodicals LLC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3532-7ec8045d677ca042c40d1e3f2760426408cbf4944bee91b1c9be0d1860cfe043
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-8621-8235
0000-0001-5864-5125
PMID 36511421
PQID 2777275054
PQPubID 986345
PageCount 7
ParticipantIDs proquest_miscellaneous_2754049214
proquest_journals_2777275054
pubmed_primary_36511421
crossref_primary_10_1002_ccd_30522
crossref_citationtrail_10_1002_ccd_30522
wiley_primary_10_1002_ccd_30522_CCD30522
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 1, 2023
PublicationDateYYYYMMDD 2023-02-01
PublicationDate_xml – month: 02
  year: 2023
  text: February 1, 2023
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Washington
PublicationTitle Catheterization and cardiovascular interventions
PublicationTitleAlternate Catheter Cardiovasc Interv
PublicationYear 2023
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2021; 14
2015; 28
2021; 21
2009; 74
2009; 95
2013; 99
2020; 30
2017; 10
2018; 137
2021; 161
2022; 43
2011; 4
2013; 6
2016; 9
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_14_1
e_1_2_7_13_1
e_1_2_7_12_1
e_1_2_7_11_1
e_1_2_7_10_1
References_xml – volume: 28
  start-page: 279
  issue: 3
  year: 2015
  end-page: 287
  article-title: Investigators of the working group interventional cardiology of the German society of pediatric cardiology. Stenting of native right ventricular outflow tract obstructions in symptomatic infants
  publication-title: J Interv Cardiol
– volume: 10
  start-page: 1774
  issue: 17
  year: 2017
  end-page: 1784
  article-title: Stenting of the right ventricular outflow tract promotes better pulmonary arterial growth compared with modified Blalock‐Taussig shunt palliation in tetralogy of fallot‐type lesions
  publication-title: JACC Cardiovasc Interv
– volume: 21
  start-page: 9
  issue: 1
  year: 2021
  article-title: Arterial duct stent versus surgical shunt for patients with duct‐dependent pulmonary circulation: a meta‐analysis
  publication-title: BMC Cardiovasc Disord
– volume: 4
  start-page: 602
  issue: 6
  year: 2011
  end-page: 614
  article-title: Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient‐related and procedural risk factors in the US Melody Valve Trial
  publication-title: Circ Cardiovasc Interv
– volume: 74
  start-page: 144
  issue: 1
  year: 2009
  end-page: 147
  article-title: Coronary compression caused by stenting a right pulmonary artery conduit
  publication-title: Catheter Cardiovasc Interv
– volume: 99
  start-page: 1603
  year: 2013
  end-page: 1608
  article-title: Stenting of the right ventricular outflow tract
  publication-title: Heart
– volume: 6
  start-page: 535
  year: 2013
  end-page: 542
  article-title: Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: a multicenter experience
  publication-title: Circ Cardiovasc Interv
– volume: 9
  issue: 12
  year: 2016
  article-title: Right ventricular outflow tract stenting in tetralogy of fallot infants with risk factors for early primary repair
  publication-title: Circ Cardiovasc Interv
– volume: 161
  start-page: 379
  issue: 2
  year: 2021
  end-page: 390
  article-title: Duct stenting versus modified Blalock‐Taussig shunt in neonates and infants with duct‐dependent pulmonary blood flow: a systematic review and meta‐ analysis
  publication-title: J Thorac Cardiovasc Surg
– volume: 95
  start-page: 142
  issue: 2
  year: 2009
  end-page: 147
  article-title: Stenting of the right ventricular outflow tract in the symptomatic infant with tetralogy of Fallot
  publication-title: Heart
– volume: 137
  start-page: 589
  issue: 6
  year: 2018
  end-page: 601
  article-title: Comparison between patent ductus arteriosus stent and modified Blalock‐ Taussig shunt as palliation for infants with ductal‐dependent pulmonary blood flow: insights from the congenital catheterization research collaborative
  publication-title: Circulation
– volume: 14
  issue: 3
  year: 2021
  article-title: Patent ductus arteriosus stenting for all ductal‐dependent cyanotic infants: waning use of Blalock‐Taussig shunts
  publication-title: Circ Cardiovasc Interv
– volume: 43
  start-page: 8
  issue: 1
  year: 2022
  end-page: 16
  article-title: Coronary artery anomalies and their impact on the feasibility of percutaneous pulmonary valve implantation
  publication-title: Pediatr Cardiol
– volume: 30
  start-page: 1469
  issue: 10
  year: 2020
  end-page: 1472
  article-title: Catheter‐based palliation for infants with tetralogy of Fallot
  publication-title: Cardiol Young
– ident: e_1_2_7_4_1
  doi: 10.1136/heartjnl-2013-304155
– ident: e_1_2_7_9_1
  doi: 10.1016/j.jtcvs.2020.06.008
– ident: e_1_2_7_2_1
  doi: 10.1017/S1047951120002334
– ident: e_1_2_7_10_1
  doi: 10.1161/CIRCULATIONAHA.117.029987
– ident: e_1_2_7_3_1
  doi: 10.1136/hrt.2007.135723
– ident: e_1_2_7_12_1
  doi: 10.1161/CIRCINTERVENTIONS.113.000202
– ident: e_1_2_7_6_1
  doi: 10.1161/CIRCINTERVENTIONS.116.003979
– ident: e_1_2_7_15_1
  doi: 10.1161/CIRCINTERVENTIONS.111.965616
– ident: e_1_2_7_11_1
  doi: 10.1016/j.jcin.2017.06.023
– ident: e_1_2_7_13_1
  doi: 10.1007/s00246-021-02684-0
– ident: e_1_2_7_14_1
  doi: 10.1002/ccd.21928
– ident: e_1_2_7_8_1
  doi: 10.1186/s12872-020-01817-2
– ident: e_1_2_7_5_1
  doi: 10.1111/joic.12198
– ident: e_1_2_7_7_1
  doi: 10.1161/CIRCINTERVENTIONS.120.009520
SSID ssj0009629
Score 2.400474
Snippet Background While right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and...
While right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and similar...
BackgroundWhile right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 372
SubjectTerms Aorta
Cardiovascular disease
catheter intervention
Catheters
Congenital diseases
Diuretics
Fluoroscopy
Heart
Hypoxia
hypoxic spells
Implants
Palliation
Patients
right ventricular outflow tract
stenting
Surgery
Tetralogy of Fallot
Ventricle
Title Rescue right ventricular outflow tract stenting for refractory hypoxic spells
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fccd.30522
https://www.ncbi.nlm.nih.gov/pubmed/36511421
https://www.proquest.com/docview/2777275054
https://www.proquest.com/docview/2754049214
Volume 101
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA7iQbz4fqwvonjw0jVJ07TFk6yKCOtBFDwIJUlTFJetbFt8_Hon6UN8gXgrdErSZCb5Jpn5BqH9WBJFJcs8mqrA4wZMUflUepFIQxKkREahTXAeXorzG35xG9xOoaM2F6bmh-gO3KxluPXaGrhUxeEHaajWaR-Uldn118ZqWUB09UEdFQtXoQy2J-aBoy5aViHCDrsvP-9F3wDmZ7zqNpyzeXTXdrWOM3nsV6Xq67cvLI7__JcFNNcAUXxca84imjLjJTQzbK7al9HwyhS6Mth579hGRbqjQjnBeVVmo_wZlzbBCoOWuGITGNAvhl-cuAI-r_j-9Sl_edC4sNc7xQq6Pju9Hpx7Te0FT_uBD6Db6AjQXirCUEswbM1JSo2fsVBYr4uTSKuMx5wrY2KqqI6VAYlIEJ0Zwv1VND3Ox2YdYUIUYEgDME34XNJMpT6ACE2pClimhd9DB-0kJLrhJbflMUZJzajMEhidxI1OD-11ok81GcdPQlvtTCaNPRYJC8GLAHAU8B7a7V6DJdnrETk2eWVlAL3ymFGQWas1oGsF9MsmHVPorJvH35tPBoMT97Dxd9FNNGur2NfB4FtoupxUZhuwTql2nFK_A0nP-CI
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hkFouhZZHl0Jxqx56yeJXnETqBS1F25blgLYSFxTFjqNWRRu0m6jAr2fsPBC0lSpukTKRHXvG_saP7wP4kGRUs4wXAct1GEiLoagFy4JY5RENc5rFkbvgPDlV4-_y63l4vgSfurswDT9Ev-DmIsOP1y7A3YL0wT1rqDH5EL2V4wC84hS9fUJ1dk8elSivUYYTFA8wVVcdrxDlB_2nD2ejPyDmQ8Tqp5zjNbjoKtucNPk1rCs9NLePeByf-jfr8KLFouSwcZ6XsGRnr-DZpN1t34DJmV2Y2hKfwBN3MNKvFmZzUtZVcVn-JpW7Y0XQUbzeBEEATPAf517D54b8uLkqr38asnA7PItNmB5_no7GQSu_EBgRCsTd1sQI-HIVRSbD2DaS5syKgkfKJV6SxkYXMpFSW5swzUyiLVrEiprCUim2YHlWzuxrIJRqhJEWkZoSMmOFzgXiCMOYDnlhlBjAx64XUtNSkzuFjMu0IVXmKbZO6ltnAO9706uGj-NvRrtdV6ZtSC5SHmEigfgolAN417_GYHI7JNnMlrWzQQArE87QZrtxgb4UgS7GJGdYWd-R_y4-HY2O_MPO_5vuw_PxdHKSnnw5_fYGVp2ofXM2fBeWq3lt9xD6VPqt9_A7zDP8PQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9wwEB5CAqEvSXok2SRt1dKHvnijy7JNn8pul6TthhJSyEPAWLJMSsN62bXJ8es7ko-QHlDyZvAIXTPSN5LmG4B3SUY1y3gRsFyHgbRoilqwLIhVHtEwp1kcuQDn6Yk6-i4_n4fnK_Chi4Vp-CH6AzdnGX69dgY-z4vDe9JQY_IhKivH9XdNKho7lR6f3nNHJcqnKMP9iQfoqauOVojyw77ow83oD4T5ELD6HWeyCRddW5uHJj-HdaWH5u43GsdHdmYLNlokSj42qvMUVuzsGaxP27v25zA9tUtTW-Ldd-KeRfqzwmxByroqrsprUrkIK4Jq4rNNEIS_BLu48Bl8bsnl7by8-WHI0t3vLF_A2eTT2egoaJMvBEaEAlG3NTHCvVxFkcnQso2kObOi4JFybpeksdGFTKTU1iZMM5NoixKxoqawVIptWJ2VM7sLhFKNINIiTlNCZqzQuUAUYRjTIS-MEgN4301Calpicpcf4yptKJV5iqOT-tEZwNtedN6wcfxN6KCbybQ1yGXKI3QjEB2FcgBv-t9oSu5-JJvZsnYyCF9lwhnK7DQa0NciVOiijhk21s_jv6tPR6Ox_9j7f9HXsP5tPEm_Hp982YcnLqN98zD8AFarRW1fIu6p9Cuv378A9LD69Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rescue+right+ventricular+outflow+tract+stenting+for+refractory+hypoxic+spells&rft.jtitle=Catheterization+and+cardiovascular+interventions&rft.au=Sasikumar%2C+Navaneetha&rft.au=Mohanty%2C+Satish&rft.au=Balaji%2C+Seshadri&rft.au=Kumar%2C+Raman+Krishna&rft.date=2023-02-01&rft.issn=1522-1946&rft.eissn=1522-726X&rft.volume=101&rft.issue=2&rft.spage=372&rft.epage=378&rft_id=info:doi/10.1002%2Fccd.30522&rft.externalDBID=10.1002%252Fccd.30522&rft.externalDocID=CCD30522
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1522-1946&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1522-1946&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1522-1946&client=summon